Rheumatoid Arthritis Clinical Trials in Chicago

Showing 1701-1720 of 3,348 trials

A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption

NCT03115567

This randomized, controlled, phase II clinical study is designed to assess the efficacy of preemptive treatment with topical steroids in preventing the papulopustular eruption induced by epidermal growth factor receptor inhibitor (EGFRI) treatment in cancer patients. Participants will be followed up for 6 weeks of twice daily application of triamcinolone cream to the face, chest, and back.

Acneiform RashPapulopustular Eruption

Northwestern University14 participantsStarted Feb 2017

Chicago, Illinois, United States

WITHDRAWNPhase 1/22.2 miles

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

NCT05251038

This is a multicenter, non-randomized, open-label, phase Ib/II study to evaluate the safety, tolerability and efficacy of sotorasib in combination with chemotherapy for patients with advanced KRAS p.G12C mutant pancreatic cancer with progression of disease after first line treatment. There will be a safety lead in to determine the safety and tolerability of the sotorasib in combination with standard chemotherapy. A Simon two-stage design will be employed to evaluate the efficacy of sotorasib in combination with standard of care second line chemotherapy.

Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic Cancer+1 more

Devalingam MahalingamStarted Sep 2022

Chicago, Illinois, United States

COMPLETEDPhase 22.2 miles

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

NCT03230838

This study aims to evaluate the safety and tolerability of MK-7625A (ceftolozane/tazobactam) compared with that of meropenem in pediatric participants with cUTI, including pyelonephritis.

Complicated Urinary Tract InfectionPyelonephritis

Merck Sharp & Dohme LLC134 participantsStarted Apr 2018

Los Angeles, California, United States • Orange, California, United States • San Diego, California, United States +49 more locations

A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

Rheumatoid Arthritis Trials in Other Cities

Psychological Symptoms and Families of COVID-19 Patients

Intervention for Pre-Frailty and Frailty in Thoracic Surgery Patients

Relative Bioavailability of LY03010 Compared to Listed Drug

Randomized Trial in Adult Participants With Acute Migraines

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

rhBMP-2/CRM/CD HORIZON® Spinal System Pivotal Study

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

FX-322 in Adults With Stable Sensorineural Hearing Loss

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

Ganaxolone Treatment in Children With Fragile X Syndrome

Other Conditions in Chicago